Table 5.
QTc Abnormalities and Medical Outcomes
| Patient No. | QTc Baseline | QTc Peak | Concurrent QTc-Prolonging Drugs | Medical Response | Finished Course of Bedaquiline? |
|---|---|---|---|---|---|
| 1 | 384 | 469 | CFZ | None | Yes |
| 3 | 439 | 507 | CFZ, LFX | Bedaquiline discontinued | No |
| 4 | 411 | 475 | CFZ, LFX | None | Yes |
| 11 | 442 | 536 | MFX | None because QTc was 432 the day after the peak value | Yes |
| 12 | 400 | 610 | LFX | K+ = 2.2; bedaquiline stopped and restarted two weeks after K+ replenished | Yes |
| 14 | 483 (3 months after bedaquiline started) | 546 (1 day after bedaquiline was stopped) | MFX, CFZ, Effexor, Zofran | MFX and CFZ stopped sequentially until QTc decreased | Yes |
Abbreviations: CFZ, clofazimine; LFX, levofloxacin; K+, potassium; MFX, moxifloxacin; QTc, corrected QT interval.